Nurse Practitioner, Family · Brooklyn, NY
NPI
1033576863
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4050 Nostrand Ave Ste 1m
Brooklyn, NY, 11235
Phone (347) 450-6040
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
392 services
Medicare patients, 2024
40
Average age 73
Drug cost, 2024
$1.3M
2,123 prescriptions
Company payments, 2025
$3,292
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yana Ryzhakova was code 99213 (office e&m - established), 37 times for 24 patients. In total Yana Ryzhakova billed 392 services in 36 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 37 | 24 | $60.40 | $2,235 |
| 99214 Office E&M - Established | Office | 34 | 17 | $90.44 | $3,075 |
By year: 2022 $22K for 400 services; 2023 $42K for 661 services; 2024 $16K for 392 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 12 | $8.40 | $202 |
Medicare prescription drug claims, 2024
In 2024, the drug Yana Ryzhakova prescribed most often to Medicare patients was Opzelura (Ruxolitinib Phosphate), with 153 prescriptions and refills. In total Yana Ryzhakova wrote 2,123 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opzelura Ruxolitinib Phosphate | 153 | 159 | 26 | $299K |
| Ketoconazole Generic | 105 | 108 | 22 | $8,552 |
| Ciclopirox Generic | 56 | 58 | Under 11 | $1,225 |
| Diclofenac Sodium Generic | 55 | 77 | 12 | $60K |
| Jublia Efinaconazole | 46 | 46 | 13 | $62K |
| Omeprazole Generic | 45 | 47 | Under 11 | $466 |
| Icosapent Ethyl Generic | 45 | 47 | Under 11 | $5,626 |
| Metformin Hcl Generic | 42 | 62 | Under 11 | $59K |
| Ammonium Lactate Generic | 37 | 37 | Under 11 | $811 |
| Rosuvastatin Calcium Generic | 36 | 38 | Under 11 | $108 |
| Mounjaro Tirzepatide | 33 | 33 | Under 11 | $32K |
| Hydrochlorothiazide Generic | 33 | 33 | Under 11 | $25.45 |
| Linzess Linaclotide | 33 | 33 | Under 11 | $16K |
| Metformin Er Gastric Metformin Hcl | 33 | 33 | Under 11 | $4,627 |
| Clobetasol Propionate Generic | 32 | 32 | Under 11 | $1,664 |
Brand drugs: 670 claims; generic drugs: 1,392 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yana Ryzhakova $3,292 ($3,292 in general payments such as food, travel and fees) from 17 companies. The largest payer was Axsome Therapeutics, Inc. with $473.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 12 | $473 |
| Abbvie Inc. ABBV | 9 | $425 |
| Incyte Corporation INCY | 14 | $349 |
| Pfizer Inc. PFE | 14 | $348 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $245 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $227 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 7 | $210 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $205 |
| Alkermes, Inc. ALKS | 2 | $151 |
| Aimmune Therapeutics, Inc. | 1 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.